Stocks · Health care · Pharmaceutical Preparations

Theravance Biopharma, Inc.

TBPH Clue Score61
United States Fiscal year ends December CIK 0001583107 Results filed 10 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Rhonda Farnum
15 Sep 2026
SVP, Comm & Medical Affairs
Sold on a plan
6,657
$17.03
$113.40K
Rhonda Farnum
15 Sep 2026
SVP, Comm & Medical Affairs
Sold on a plan
3,328
$17.03
$56.69K
Rhonda Farnum
15 Sep 2026
SVP, Comm & Medical Affairs
Sold on a plan
3,329
$17.03
$56.71K
Rhonda Farnum
15 Jun 2026
SVP, Comm & Medical Affairs
Sold on a plan
6,657
$16.39
$109.08K
Rhonda Farnum
15 Jun 2026
SVP, Comm & Medical Affairs
Sold on a plan
3,328
$16.38
$54.53K
Rhonda Farnum
15 Jun 2026
SVP, Comm & Medical Affairs
Sold on a plan
3,329
$16.39
$54.56K
Rhonda Farnum
16 Mar 2026
SVP, Comm & Medical Affairs
Sold on a plan
7,766
$13.92
$108.07K
Rhonda Farnum
16 Mar 2026
SVP, Comm & Medical Affairs
Sold on a plan
15,534
$14.00
$217.48K
Rhonda Farnum
16 Mar 2026
SVP, Comm & Medical Affairs
Sold on a plan
7,767
$13.92
$108.09K
Rhonda Farnum
3 Dec 2025
SVP, Comm & Medical Affairs
Sold on a plan
15,534
$18.75
$291.25K
Rhonda Farnum
3 Dec 2025
SVP, Comm & Medical Affairs
Sold on a plan
7,766
$18.75
$145.62K
Rhonda Farnum
3 Dec 2025
SVP, Comm & Medical Affairs
Sold on a plan
7,767
$18.75
$145.63K
Rhonda Farnum
14 Jul 2025
SVP, Comm & Medical Affairs
Sold on a plan
4,000
$11.39
$45.55K
Rhonda Farnum
14 Jul 2025
SVP, Comm & Medical Affairs
Sold on a plan
5,318
$11.39
$60.55K
Rhonda Farnum
14 Jul 2025
SVP, Comm & Medical Affairs
Sold on a plan
682
$11.39
$7.77K
Rhonda Farnum
2 Jun 2025
SVP, Comm & Medical Affairs
Sold on a plan
24,000
$11.00
$264.00K
Rhonda Farnum
21 Apr 2025
SVP, Comm & Medical Affairs
Sold on a plan
4,000
$9.00
$36.00K
Rhonda Farnum
21 Jan 2025
SVP, Comm & Medical Affairs
Sold on a plan
4,000
$9.00
$36.00K
Rhonda Farnum
10 Jul 2024
SVP, Comm & Medical Affairs
Sold on a plan
4,000
$9.00
$36.00K
Rhonda Farnum
22 Feb 2024
SVP, Comm & Medical Affairs
Sold on a plan
1,254
$8.71
$10.92K
Rhonda Farnum
21 Nov 2023
SVP, Comm & Medical Affairs
Sold on a plan
1,378
$10.29
$14.18K
Richard A Graham
14 Nov 2023
SVP, Research & Development
Sold on a plan
2,482
$10.22
$25.37K
Richard A Graham
16 Oct 2023
SVP, Research & Development
Sold on a plan
2,482
$9.03
$22.41K
Richard A Graham
14 Sep 2023
SVP, Research & Development
Sold on a plan
2,482
$9.89
$24.55K
Rhonda Farnum
22 Aug 2023
SVP, Comm & Medical Affairs
Sold on a plan
1,807
$9.47
$17.11K
Richard A Graham
11 Aug 2023
SVP, Research & Development
Sold on a plan
2,322
$9.99
$23.20K

What was left out

Form 4 filings counted 515
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 1
Joint filings 1
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 5
Sales at will 44
Transactions with no price 0
Shares from compensation/vesting 30,222,989
Sales filed before the plan box existed 35
History held since 19 May 2014